Application

CAVIVA

AstraZeneca AB

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 90532519
Filing Date: 02/17/2021

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90532519
MARK INFORMATION
*MARK CAVIVA
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT CAVIVA
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK AstraZeneca AB
*MAILING ADDRESS Astraallén
*CITY Södertälje
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Sweden
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
SE-15185
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE aktiebolag (ab)
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED Sweden
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations and substances
FILING BASIS SECTION 1(b)
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER 018299584
       FOREIGN APPLICATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
European Union Trademark - EUTM
       FOREIGN FILING DATE 08/31/2020
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
ATTORNEY INFORMATION
NAME Wm. Charles Saunders
ATTORNEY DOCKET NUMBER 103885/US
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME AstraZeneca Pharmaceuticals LP
INTERNAL ADDRESS A2C
STREET 1800 Concord Pike
CITY Wilmington
STATE Delaware
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 19850-5437
PHONE 302-886-6934
FAX 3028853762
EMAIL ADDRESS chuck.saunders@astrazeneca.com
CORRESPONDENCE INFORMATION
NAME Wm. Charles Saunders
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE chuck.saunders@astrazeneca.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) trademarks@astrazeneca.com; paula.wright@astrazeneca.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 350
*TOTAL FEES PAID 350
SIGNATURE INFORMATION
SIGNATURE /wcs/
SIGNATORY'S NAME Wm. Charles Saunders
SIGNATORY'S POSITION Attorney of record, Pennsylvania Bar member
SIGNATORY'S PHONE NUMBER 302-886-6934
DATE SIGNED 02/17/2021
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 90532519
Filing Date: 02/17/2021

To the Commissioner for Trademarks:

MARK: CAVIVA (Standard Characters, see mark)
The literal element of the mark consists of CAVIVA. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, AstraZeneca AB, a aktiebolag (ab) legally organized under the laws of Sweden, having an address of
      Astraallén
      Södertälje SE-15185
      Sweden
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations and substances
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on European Union Trademark - EUTM application number 018299584, filed 08/31/2020.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.




The owner's/holder's proposed attorney information: Wm. Charles Saunders. Wm. Charles Saunders of AstraZeneca Pharmaceuticals LP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at
      A2C
      1800 Concord Pike
      Wilmington, Delaware 19850-5437
      United States
      302-886-6934(phone)
      3028853762(fax)
      chuck.saunders@astrazeneca.com
The docket/reference number is 103885/US.
Wm. Charles Saunders submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Wm. Charles Saunders
       PRIMARY EMAIL FOR CORRESPONDENCE: chuck.saunders@astrazeneca.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): trademarks@astrazeneca.com; paula.wright@astrazeneca.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /wcs/   Date: 02/17/2021
Signatory's Name: Wm. Charles Saunders
Signatory's Position: Attorney of record, Pennsylvania Bar member
Signatory's Phone Number: 302-886-6934
Signature method: Sent to third party for signature
Payment Sale Number: 90532519
Payment Accounting Date: 02/17/2021

Serial Number: 90532519
Internet Transmission Date: Wed Feb 17 16:25:13 ET 2021
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XXX-2021021716251367
5587-90532519-77062b59c1a855bf7594470d88
4ccfcb863c12d855acdf277e1c3d01b14e1f7c6d
8-DA-25133578-20210217100416203142

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed